國博電子(688375.SH):多款T/R組件產品已開始交付低軌衞星客户
格隆匯7月17日丨國博電子(688375.SH)在互動平台表示,公司生產經營正常進行,公司半年度報吿將於2024年8月26日在公司指定信息披露平台公吿,請您及時關注公司後續披露的公吿。公司依託化合物半導體方面的技術積累,緊跟行業發展趨勢,佈局研製開發基於異構集成的射頻微系統技術,推進T/R組件頻譜往更高頻段發展,開發更高規模集成度T/R陣列,拓寬產品類別;積極開拓終端領域,多款終端用射頻芯片產品已經開始向業內知名終端廠商批量供貨;在衞星互聯網領域,公司多款T/R組件產品已開始交付低軌衞星客户,多款射頻集成電路產品被衞星通信客户引入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.